No retraction, correction or concern found when last checked on Oct 28, 2026.
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
Deepa R.J. Arachchillage, Mike Laffan
Journal of Thrombosis and Haemostasis · 2020
References 5
- 1.
Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844‐847.
Not in our library10.1111/jth.14768
- 2.
Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001;86:1327‐1330.
Not in our library
- 3.
Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020.. [Epub ahead of print]
Not in our library10.1001/jamainternmed.2020.0994
- 4.
Arachchillage DRJ, Laffan M, Khanna S, et al. Frequency of thrombocytopenia and heparin‐induced thrombocytopenia in patients receiving extracorporeal membrane oxygenation compared with cardiopulmonary bypass and the limited sensitivity of pretest probability score. Crit Care Med. 2020;48:e371‐e379.
Not in our library10.1097/ccm.0000000000004261
- 5.
Arachchillage DRJ, Passariello M, Laffan M, et al. Intracranial hemorrhage and early mortality in patients receiving extracorporeal membrane oxygenation for severe respiratory failure. Semin Thromb Hemost. 2018;44(3):276‐286.
Not in our library10.1055/s-0038-1636840
Cited by papers we hold 5
- Pulmonary embolism in COVID-19 · 2022Not checked
- Myocardial Injury in COVID-19 and Its Implications in Short- and Long-Term Outcomes · 2022Not checked
- NETosis and Neutrophil Extracellular Traps in COVID-19: Immunothrombosis and Beyond · 2022No notice
- B Cell Subsets as Severity-Associated Signatures in COVID-19 Patients · 2020No notice
- MSC Therapies for COVID-19: Importance of Patient Coagulopathy, Thromboprophylaxis, Cell Product Quality and Mode of Delivery for Treatment Safety and Efficacy · 2020No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.